Contrast medical products Second Sight (NASDAQ:EYES) and Electromed (NYSE:ELMD)
Second Sight Medical Products (NASDAQ:EYES – Get Rating) and Electromed (NYSE:ELMD – Get Rating) are both small-cap medical companies, but which is the better company? We’ll compare the two companies based on their dividend strength, analyst recommendations, earnings, institutional ownership, profitability, valuation, and risk.
Risk and Volatility
Second Sight Medical Products has a beta of 2.85, which means its stock price is 185% more volatile than the S&P 500. In comparison, Electromed has a beta of 0.57, which means its stock price is 43 % less volatile than the S&P 500.
This table compares the net margins, return on equity and return on assets of Second Sight Medical Products and Electromed.
|Net margins||Return on equity||return on assets|
|Second Sight Medical Products||N / A||-15.44%||-14.36%|
This is a breakdown of current ratings and recommendations for Second Sight Medical Products and Electromed, as reported by MarketBeat.com.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|Second Sight Medical Products||0||0||0||0||N / A|
|Electromed||0||0||0||0||N / A|
Benefits and evaluation
This chart compares revenue, earnings per share, and valuation of Second Sight Medical Products and Electromed.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|Second Sight Medical Products||$3.38 million||21.57||-8.92 million dollars||N / A||N / A|
|Electromed||$35.76 million||2.88||$2.36 million||$0.26||46.42|
Electromed has higher revenues and profits than Second Sight Medical Products.
Institutional and Insider Ownership
9.1% of Second Sight Medical Products shares are held by institutional investors. Comparatively, 32.7% of Electromed shares are held by institutional investors. 47.2% of the shares of Second Sight Medical Products are held by insiders of the company. Comparatively, 26.7% of Electromed shares are held by company insiders. Strong institutional ownership indicates that large fund managers, hedge funds, and endowments believe a stock is poised for long-term growth.
Electromed beats Second Sight Medical Products on 6 out of 9 factors compared between the two stocks.
About Second Sight medical products (Get a rating)
Second Sight Medical Products, Inc. develops, manufactures and markets implantable vision prostheses intended to provide artificial vision to people who are blind. It develops technologies to treat the population of visually impaired people. The Company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, intended to provide useful artificial vision to people who are blind due to a variety of causes, including glaucoma, diabetic retinopathy, optic nerve damage or disease, and eye damage. The company was founded in 1998 and is based in Sylmar, California.
About Electromed (Get a rating)
Electromed, Inc. develops, manufactures, markets and sells airway clearance therapy and related products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the States United and around the world. The company offers the SmartVest airway clearance system; SmartVest SQL System which consists of an inflatable therapy garment, a programmable air pulse generator and a unique patented hose that delivers pulses of air from the generator to the garment; and SmartVest Connect, a wireless technology with a personalized HFCWO therapy management portal for patients with compromised lung function. It also provides single-use SmartVest and SmartVest Wrap products for healthcare providers in acute care settings. The Company offers its products primarily to the home healthcare market for patients with bronchiectasis, cystic fibrosis and neuromuscular diseases. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is based in New Prague, Minnesota.
Receive daily news and reviews for Second Sight medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Second Sight Medical Products and related companies with MarketBeat.com’s FREE daily newsletter.